It is not only our excellent scientists that our success is due to. A broad network, both national and international, and numerous cooperation partners represent a crucial factor in our expertise. Fraunhofer ITEM’s network includes other Fraunhofer Institutes that we collaborate with in Fraunhofer Groups, Alliances and Research Clusters, but also universities, research institutions and companies in Germany and all over the world.
The Fraunhofer Group for Life Sciences generates innovative knowledge to seek scientific solutions. The Fraunhofer Institutes pool their expertise to offer a broad spectrum of services and promote cooperation. Expert solutions for your contract research are thus guaranteed.
What characterizes the research performed in the Fraunhofer Group for Life Sciences is its closeness to industrial application, aiming to develop solutions that meet clients’ actual requirements, always with a view to economic efficiency and sustainability. In addition, the institutes also undertake basic research to develop the basis for future applications in industry. The business units of the Fraunhofer Group for Life Sciences include translational medicine research and biomedical technology, regenerative medicine, healthy foodstuffs, industrial biotechnology, and research aimed at the safety of processes, chemicals, and pesticides.
The Group shows ways of preserving health and the environment in an industrialized world and develops new options for diagnosing and treating diseases in a setting of a more personalized healthcare and for protecting natural resources.
The primary goal of the Fraunhofer Cluster of Excellence for Immune-Mediated Diseases is the translation of innovative ideas and identified targets into individualized therapies for immune-mediated diseases. The collaborating institutes want to bridge the existing gap from research on novel medications to what is actually available to patients.
In forward-looking projects, three Fraunhofer Institutes – Fraunhofer IME, Fraunhofer IZI, and Fraunhofer ITEM – are pooling their expertise, thereby enabling efficient translation. A substantial gain of knowledge in the pathophysiology of immune diseases will thus be generated, innovative targets will be addressed, and new treatment categories in this therapeutic area will be introduced and established.
Dr. Annette Bitsch
Working committee on probabilistic exposure and risk assessment “Probabilistische Expositions- und Risikoabschätzung”
Expert panel 110 on cooling lubricants “Kühlschmierstoffe” of the Association of German Engineers (VDI) Technical Division 1 “Production Technology and Manufacturing Methods”
Reviewer for international journals published by Elsevier (incl. “Regulatory Toxicology and Pharmacology”)
Katharina Blümlein Ph.D.
Working group on analyses in biological materials “Analysen in biologischem Material” of the German Research Foundation (DFG)
Prof. Dr. Armin Braun
MD/Ph.D. commission “Molecular Medicine” of the Hannover Medical School
Scientific advisory committee of the German Society for Allergology and Clinical Immunology (DGAKI)
German Center for Lung Research (DZL)
External assessor for international foundations
Reviewer for international journals in respiratory medicine and immunology (incl. “Journal of Allergy and Clinical Immunology”)
Dr. Otto Creutzenberg
Reviewer for international journals in particle and fiber toxicology (“Particle and Fibre Toxicology”, “Inhalation Toxicology”)
Prof. Dr. Theodor Doll
VDE/VDI Society Microelectronics, Microsystems and Precision Engineering GMM, chair of the expert panel on microsystems in medicine/functional surfaces “FA 4.6 Mikrosysteme in der Medizin/Funktionale Oberflächen”
German Society for Biomedical Engineering DGBMT, expert panel on sensor technology ”Sensorik”
Reviewer in the European Commission’s Marie Skłodowska-Curie Actions (MSCA) program, expert in the work packages “Biomedical Technologies” and Sensors of the EU Graphene Flagship
ASIIN reviewer for biomedical engineering careers
Guest editor of the journal “Physica Status Solidi (a)”
Uta Dörfel
Working groups on GLP analytics “GLP-Analytik” and medical devices “Medizinprodukte” of the German Quality Management Association (GQMA)
Dr. Jens Gerdelmann
Working groups on GLP quality assurance/monitoring “GLP: Qualitätssicherung/Überwachung”, GCP quality management “GCP-Qualitätsmanagement”, and medical devices "Medizinprodukte" of the German Quality Management Association (GQMA)
Dr. Stefan Hahn
Chair of the German Chemical Society (GDCh) Division of Environmental Chemistry and Ecotoxicology
Working committee on chemical risk assessment of the German Chemical Society (GDCh) division of environmental chemistry and ecotoxicology “Umweltchemie und Ökotoxikologie”
Reviewer for international journals (incl. “Annals of Work Exposures and Health” and "Environmental Science & Technology")
Dr. Roman Halter
External expert in the quality control committee of the association for mineral wool quality “Gütegemeinschaft Mineralwolle e. V.”
Martina Heina
IT division of the International Association for Pharmaceutical Technology (APV)
Prof. Dr. Jens Hohlfeld
External assessor for the German Research Foundation (DFG)
Steering committee of the research network “Biomedical Research in Endstage And ObsTructive Lung Disease Hannover” (BREATH) within the German Center for Lung Research (DZL)
Board member of the interdisciplinary allergy center of the Hannover Medical School
Reviewer for international journals (incl. "American Journal of Respiratory and Critical Care Medicine", "European Respiratory Journal" and "Journal of Allergy and Clinical Immunology")
Dr. Olaf Holz
IABR (International Association of Breath Research) Standardization Focus Group
Reviewer for international journals (incl. "American Journal of Respiratory and Critical Care Medicine", "Journal of Breath Research", "European Respiratory Journal", "PLOS ONE", "Respiratory Research", and "BMC Pulmonary Medicine")
Dr. Kamran Honarnejad
Chair of the Knowledge Content and Delivery Council (KCDC) of the Society for Laboratory Automation and Screening (SLAS)
Reviewer for the journal "SLAS Discovery"
Dr. Rupert Kellner
Councilor for electronic communication and member of the Executive Board of the European Society of Toxicologic Pathology (ESTP)
Global Editorial and Steering Committee (GESC) for the initiative "International Harmonization of Nomenclature and Diagnostic Criteria for Lesions in Rats and Mice" (INHAND)
Prof. Dr. Christoph Klein
External assessor for numerous national and international organizations and foundations: German Research Foundation, German Federal Ministry of Education and Research, Wilhelm Sander Foundation for Cancer Research, ERC, Deutsche Krebshilfe, Christian Doppler Research Association, Dutch Cancer Society, Association for International Cancer Research, EU-FP7, MRC, Cancer Research UK, Kegg-Foundation
Deputy chairman of the scientific committee of Comprehensive Cancer Center Ostbayern (CCCO)
Advisory committee of the Pezcoller Foundation-AACR International Award for Cancer Research Committee
Scientific advisory board of the AIRC (Associazione Italiana per la Ricerca sul Cancro) 5x1000 project "Cancer of Unknown Primary (CUP): the archetype of metastatic disease"
Reviewer for international journals in oncology (incl. “Nature”, “Nature Biotechnology”, “Nature Cell Biology”, “Nature Medicine”, “Cancer Cell”, “Science”, “PNAS”, “American Journal of Pathology”, “Cancer Research”, “Clinical Cancer Research”, “International Journal of Cancer”, “Nucleic Acid Research”, “European Journal of Immunology”, “Lancet Oncology”, “European Journal of Cancer”, “PLOS ONE”, and “Oncotarget”)
Prof. Dr. Wolfgang Koch
Reviewer for international journals in aerosol physics and aerosol technology (incl. “Journal of Aerosol Science”, “Aerosol Science and Technology” and “Annals of Occupational Hygiene”)
Dr. Gustav Könnecker
Working group on sustainable chemicals policy “Nachhaltige Chemikalienpolitik” of the 8th Lower Saxony Governmental Commission on sustainable environmental policy and digital change
Prof. Dr. Norbert Krug
Scientific advisory committee of the German Society for Allergology and Clinical Immunology (DGAKI)
Chair of the Clinical Trial Board of the German Center for Lung Research (DZL)
Steering committee of the research network “Biomedical Research in Endstage And ObsTructive Lung Disease Hannover” (BREATH) within the German Center for Lung Research (DZL)
External assessor for the German Research Foundation (DFG)
Steering committee of the Fraunhofer Research Cluster “Immune-Mediated Diseases” (Fraunhofer CIMD)
Advisory board of the expertise network “Asthma und COPD”
Working group “Fraunhofer-Gesellschaft and Deutsche Hochschulmedizin”
Reviewer for international journals in allergology, immunology, and respiratory diseases
Dr. Oliver Licht
Working group on sustainable chemicals policy “Nachhaltige Chemikalienpolitik” of the 8th Lower Saxony Governmental Commission on sustainable environmental policy and digital change
German Federal Institute for Risk Assessment (BfR) Committee for Contaminants in the Food Chain; panel on perfluorinated and polyfluorinated alkyl substances “Per- und Polyfluoralkylsubstanzen (PFAS)”
Expert panel “Basic moduleFraunhofer Group for Life Sciences and perfluorinated tensides” of the German Federal Institute for Risk Assessment’s MEAL (= meals for exposure assessment and analysis of foods) study within the Total Diet Study (TDS) in Germany
Working committee on regulatory toxicology “Regulatorische Toxikologie” of the German Society of Toxicology within the German Society of Clinical and Experimental Pharmacology and Toxicology (DGPT)
Public relations delegate of the German Society of Toxicology
Dr. Neophytos Papamichael
Working committee on quality management “Qualitätsmanagement im VLS” in the Fraunhofer Group for Life Sciences
GMP discussion group "GMP-Gesprächskreis" of the Lower Saxony business inspectorate
Dr. Gerhard Pohlmann
International Society for Aerosols in Medicine (ISAM)
Dr. Bernhard Polzer
External assessor for the Wilhelm Sander Foundation for Cancer Research
External assessor for the Swiss Cancer League
External assessor for the Medical Research Council (UK)
External assessor for North West Cancer Research (UK)
Reviewer for international journals in pathology and oncology (“British Journal of Cancer”, "Chemical Science", "International Journal of Cancer", “Journal of Histochemistry and Cytochemistry”, "Journal of Visualized Experiments", “Oncotarget”, "Scientific Reports", and “Thoracic Cancer”)
Prof. Dr. Antje Prasse
External assessor for the German Research Foundation (DFG)
Board member of the Scientific Working Group for the Therapy of Lung Diseases (WATL)
Board member of Deutsche Atemwegsliga e. V.
Spokesperson for the disease area “DPLD” in the research network “Biomedical Research in Endstage And ObsTructive Lung Disease Hannover” (BREATH) within the German Center for Lung Research (DZL)
Coordinator of the ILD group in the European Reference Network on Respiratory Diseases ERN-LUNG
Deputy spokesperson of the Cell Biology Section in the German Respiratory Society (DGP)
Reviewer for international journals (incl. “American Journal of Respiratory and Critical Care Medicine”, “European Respiratory Journal”, “American Journal of Respiratory and Cell Biology”, and “Thorax”)
Associate editor of “PLOS ONE”
Priv.-Doz. Dr. Susanne Rittinghausen
Co-optive member of the European Society of Toxicologic Pathology (ESTP) board: representative for nomenclature
“Guess What” committee of the European Society of Toxicologic Pathology (ESTP)
Global Editorial and Steering Committee (GESC) for the initiative "International Harmonization of Nomenclature and Diagnostic Criteria for Lesions in Rats and Mice" (INHAND)
INHAND (International Harmonization of Nomenclature and Diagnostic Criteria) organ working groups “Respiratory System”, “Endocrine System”, “Soft Tissue”, and “Special Senses”, and working group “Apoptosis”
Ad-hoc working group on inflammatory parameters and inflammatory effects "Entzündungsparameter – entzündliche Effekte"
of the DFG Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission)
Reviewer for the international journals “Toxicologic Pathology” and "Toxicology"
Dirk Schaudien Ph.D.
INHAND (International Harmonization of Nomenclature and Diagnostic Criteria) working groups “Non-rodents: Minipig”, "Skeletal Tissues (Bones, Joints, and Teeth)" and "Respiratory System"
“Pathology 2.0” committee of the European Society of Toxicologic Pathology (ESTP)
“Guess What” committee of the European Society of Toxicologic Pathology (ESTP)
Examination board of the European College of Veterinary Pathology
Dr. Stefanie Scheffler
Working group on e-cigarettes and liquids for e-cigarettes of the DIN Standards Committee "Food and Agricultural Products"
Dr. Sven Schuchardt
Treasurer of the German Society for Metabolome Research
Working group on air analyses “Luftanalysen” of the German Research Foundation (DFG)
Leibniz-Institut für Analytische Wissenschaften – ISAS – e. V. (Leibniz Institute for Analytical Sciences)
Scientific committee for the EU project FACTS (investigations to find FACTS on the subject of aircraft cabin air quality)
Dr. Florian Schulz
DFG Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission): working group on the definition of threshold limit values for dusts
Committee on Hazardous Substances (AGS) under the German Federal Minister of Labor and Social Affairs: Subcommittee III for the evaluation of hazardous substances “Gefahrstoffbewertung”, working groups on metals and fibers/dust
Advisory Board of the European Certification Board for Mineral Wool Products (EUCEB)
External expert in the quality control committee of the mineral wool quality assurance association "RAL-Güteqemeinschaft Mineralwolle" (GGM)
Dr. Katherina Sewald
Steering group of the workshop “Respiratory Toxicity”
German Center for Lung Research (DZL)
External assessor for international research grants
Reviewer for the international journals “Toxicology Letters”, “Toxicology in vitro”, “Nanotoxicology”, “ATOX”, and “PLOS ONE”
Dr. Lena Wiese
Special interest group "Digital Health" and working group "Data Science and Data Engineering" of the German Informatics Society
Dr. Dorothee Winterberg
Working group "Respiratory Toxicology" of the German Society of Toxicology (DGT)
Association of Inhalation Toxicologists (AIT)
German Center for Lung Research (DZL)
Dr. Sabine Wronski
Reviewer for the international journal “European Respiratory Journal”
Prof. Dr. Holger Ziehr
Association of German Engineers (VDI) committee “Technical Good Manufacturing Practice”
GMP discussion group "GMP-Gesprächskreis" of the Lower Saxony business inspectorate
Center for Pharmaceutical Process Engineering (PVZ) at Technische Universität Braunschweig
BioPharma-Translationsinstitut e. V.
Dr. Christina Ziemann
Working group “Genotoxicity” of the DIN Standards Committee "Water Practice“
Chair of the working group on statistics of the German Society for Environmental Mutation Research (GUM)
Working group on carcinogenesis “Carcinogenese” of the German Society of Toxicology
OECD pool of experts of the German Federal Institute for Risk Assessment
External assessor for applications submitted to the German Federal Environmental Foundation
German Pharm-Tox Summit program committee
Reviewer for international journals in genetic toxicology, nanomaterials, and quartz (incl. “Regulatory Toxicology and Pharmacology”)
Bavarian Ministry of Economic Affairs, Regional Development and Energy
Further development of Fraunhofer ITEM in Regensburg
Bayern Innovativ, funding program "Biomedical Engineering"
Project: KrEiBl
Method for blood-based cancer diagnosis at the single-cell level: molecular analysis of single cells
Deutsche Krebshilfe (German Cancer Aid) – Priority Program “Translational Oncology”
DETECT CTC: Detection and molecular characterization of circulating tumor cells and cell-free nucleic acids in advanced breast cancer in the context of tumor heterogeneity
DFG – German Research Foundation
Selection and adaptation during metastatic cancer progression. FOR 2127, project no. 242727105
Designing nanoparticle-based inhaled antibiotics for the treatment of cystic fibrosis associated biofilms and infections and in vivo studies in a rat model. Project no. 256755002
Identification of tumor-specific peptides for adjuvant immunotherapy of melanoma patients without distant metastasis. Project no. 320058447
Federal Environment Agency
Relevance of physiological and anthropometric parameters for the standardization and assessment of human biomonitoring results. R&D project 3716 62 214 0
Federal Institute for Occupational Safety and Health (BAuA)
Mode of toxic action of nanocarbons. Research project F 2376
Federal Joint Committee/Innovation Committee
PTmHBP – Practicability testing of the magistral production of bacteriophages for the therapy of septic infections of the lower extremity (PhagoFlow)
Federal Ministry for Economic Affairs and Energy, central innovation program for SMEs
Development of an ex-vivo rat lung model for quality assurance of surfactant batches without the need to simulate asphyxia
Federal Ministry of Education and Research (BMBF) action plan for individualized medicine, funding area “Innovations for individualized medicine”
Collaborative project: TurbiCAR
UniCAR-based treatment of CD19-positive lymphoblastic leukemia – subproject “Production of the anti-CD19 target module”
Federal Ministry of Education and Research (BMBF) framework program “Gesundheitsforschung” (health research)
Collaborative research project: 4-IN
Insect-derived inhalable inhibitors of bacterial virulence for treating lung infections
Collaborative research project: Phage4Cure
Developing bacteriophages as approved therapy against bacterial infections
Federal Ministry of Education and Research (BMBF) funding program “Alternatives to Animal Testing”
Project: InhalAb
Alternative models for testing of inhalable antibiotics
Federal Ministry of Education and Research (BMBF) funding program “Ersatz und Ergänzungsmethoden zum Tierversuch” (alternatives and complements to animal experiments)
Project: ExITox2 – Explain Inhalation Toxicity 2
Animal-free mechanism-based toxicity testing – predict toxicity after repeated-dose inhalation exposure by using a read-across approach
Federal Ministry of Education and Research (BMBF) funding program FlexMax: flexible active sensor matrix for medical applications
Use of sensor arrays in two different biomedical engineering systems:
sub-project "Sensorgesteuerte Atmungsüberwachung, Atmungstriggerung und Inhalation bei Frühgeborenen" (sensor-controlled breath monitoring, breath triggering, and inhalation in preterm infants)
Federal Ministry of Education and Research (BMBF) funding program "In-vitro Challenge"
ImmunAVATAR: Make your immune system great again (exploratory phase)
Federal Ministry of Education and Research (BMBF) funding program “Innovative Stammzelltechnologien für die individualisierte Medizin” (innovative stem cell technologies for individualized medicine)
Project: iCARE
Induced pluripotent stem cells for clinically applicable heart repair
Federal Ministry of Education and Research (BMBF) funding program "KMU-innovativ: Medizintechnik" (innovative SMEs: biomedical engineering)
Collaborative project: CTCbySCP
Development of a single cell printer-based method for marker-independent quantification and isolation of vital circulating tumor cells for diagnosis and personalized therapy
Federal Ministry of Education and Research (BMBF) funding program "NanoCare4.0 – application-safe material innovations"
Project: MetalSafety
Development of evaluation concepts for fibrous and granular metal compounds: bioavailability, toxicological efficacy profiles and comparative in vitro, ex vivo and in vivo studies
Project: NanoINHAL
In-vitro test methods for airborne nanomaterials to investigate toxic potential and uptake after inhalation exposure using innovative organ-on-a-chip technology
Federal Ministry of Education and Research (BMBF) funding program “Sicherer Umgang mit synthetischen Nanomaterialien – Erforschung der Auswirkungen synthetischer Nanomaterialien auf den Menschen – NanoCare” (safe handling of synthetic nanomaterials – research on the impact of synthetic nanomaterials on human health - NanoCare)
Project: CaNTser
Investigation of the toxic potency of carbon nanotubes following long time inhalation
Federal Office for Radiation Protection
Childhood leukemia – influence of the immune system on the development of the disease (experimental study in a suitable animal model)
German Center for Lung Research (DZL)
Allergy and asthma
Chronic obstructive pulmonary disease (COPD)
Diffuse parenchymal lung diseases (DPLD)
Lower Saxony Ministry of Science and Culture
Collaborative project: fibromics
Translating Omics studies into clinically relevant insights for lung fibrosis patients
EFSA project: Applying a tested procedure for the identification of potential emerging chemical risks in the food chain to the substances registered under REACH – REACH 2
EU project: ERA-Net TRANSCAN
Analysis of tumor evolution and identification of relapse-initiating tumor cells in non-small cell lung carcinoma
EU project: Eurostars TARGIT
Development of next-generation treatment for allergies: targeted glycan-allergen immunotherapy
EU project: IMI-eTranSafe
Enhancing translational safety assessment through integrative knowledge management
EU project: Immune Safety Avatar (imSAVAR)
Nonclinical mimicking of the immune system effects of immunomodulatory therapies
EU project: Marie Skłodowska-Curie Innovative Training Networks, Magicbullet :: Reloaded (Horizon 2020)
Development and employment of approaches for selective, targeted delivery of a panel of anticancer drugs for directed tumor therapy
EU project: MDOT (Medical Device Obligations Taskforce)
Establishment of a digital platform for simplified conformity assessment and testing of medical devices, including three demonstrator technologies: inhalation technology, 3D-printed neural implants, and coatings for orthopedic prostheses
EU project: REMEDIA – RElation exposoME
DIseAse Impact of exposome on the course of lung diseases
EU project: TBMED
An open innovation test bed for the development of high-risk medical devices
Translation of the quality-by-design approach of the pharmaceutical industry to biomedical engineering, using several medical devices as examples: bone defect reconstruction materials, keratoprosthesis, and nanoparticles for cancer treatment
EU project: ToxRisk (Horizon 2020)
An Integrated European ‘Flagship’ Programme Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st century
German Federal Ministry of Education and Research (BMBF) and Ministry of Research, Technology and Higher Education of the Republic of Indonesia (RISTEK): joint research program for the identification and use of natural substances from Indonesia for the development of new therapeutics
Collaborative research project: Triple-IN
Insect-derived anti-infectives from Indonesia
Prof. Dr. Armin Braun
TRAIN Academy: professional education program "Translational Research & Medicine: From Idea to Product” (lecturer and person in charge of Module 6 “Preclinical development”)
Hannover Medical School: lectures in the MD/Ph.D. program “Molecular Medicine”
Lower Saxony International Summer Academy in Immunology at the Hannover Medical School: lecture on neuroimmune interactions in allergic asthma in the session “Lung Inflammation, Asthma, Allergy”
Dr. Otto Creutzenberg
University of Leipzig: lecture on inhalation toxicology in the postgraduate course “Toxicology and Environmental Protection”
Universities of Jena/Erfurt, Institute for Pharmacology and Toxicology: lecture on exposure methods/toxicokinetics within the DGPT course “Fundamentals of organ toxicology and organ pathology”
Dr. Zbigniew Czyz
University of Regensburg: course in pathology in the degree course “Molecular Medicine”
Prof. Dr. Theodor Doll
Leibniz University Hannover: lecture on polymers for implant production in the degree course “Biomedical Engineering”; two lectures ("General introduction to regulatory affairs" and "Standards in biomedical engineering") as part of the series of lectures "Introduction to regulatory affairs and quality management in biomedical engineering"
Hannover Medical School: postgraduate training course in nanomedicine
Jade University of Applied Sciences Wilhelmshaven: lecture on biomechanics, breathing and neuro-rehabilitation in the degree course “Medical Technology“
TRAIN Academy: lectures on economic aspects in implant development
Dr. Ulrich Froriep
Leibniz University Hannover: lecture ("Digitalization in biomedical engineering") as part of the series of lectures "Introduction to regulatory affairs and quality management in biomedical engineering"
Prof. Dr. Edward Geissler
University of Regensburg: lecture on methods in transplantation immunology; practical exercises with experimental animal models for research on tumor angiogenesis; laboratory course for staff and Ph.D. students; lab meeting with Ph.D. students; Journal Club
Dr. Jens Gerdelmann
TRAIN Academy: lectures on quality management, Good Laboratory Practice (GLP), and clinical testing of medical devices (Modules 2.1, 2.6 and 5.8)
Leibniz University Hannover: lecture "Quality management (introduction)" as part of the series of lectures "Introduction to regulatory affairs and quality management in biomedical engineering"
Hannover Biomedical Research School (HBRS) at the Hannover Medical School: workshop “Introduction to GLP and GMP”
Hannover Medical School, Ph.D. programm "Regenerative Science": seminar and tutorial "Quality Management"
Prof. Dr. Jens Hohlfeld
Hannover Medical School: lectures on allergic respiratory diseases
Dr. Kamran Honarnejad
University of Regensburg: course in pathology in the degree course “Molecular Medicine”
Dr. Stefan Kirsch
University of Regensburg: lectures and hands-on training in molecular oncology in the degree course “Molecular Medicine”; hands-on training in database researches in the degree course “Computational Science”
Prof. Dr. Christoph Klein
University of Regensburg: lectures in pathology and molecular oncology in the degree course “Molecular Medicine”; course and hands-on training in molecular oncology; lectures on pathology in the degree course “Human Medicine”; methodology seminar "Experiment and analysis" for Ph.D., master, and bachelor students of the Chair of Experimental Medicine and Therapy Research
Dr. Oliver Licht
Leuphana University Lüneburg: lectures on toxicology and ecotoxicology in the professional Master's program "M.Sc. Sustainable Chemistry"
RWTH Aachen: lectures in toxicology and risk assessment
Dr. Gerhard Pohlmann
TRAIN Academy: lectures on economic aspects in implant development and in Module 6 “Preclinical Development of Medical Devices”
Dr. Bernhard Polzer
University of Regensburg: lectures on molecular oncology in the degree course “Molecular Medicine”; hands-on training in molecular oncology
Prof. Dr. Antje Prasse
Hannover Medical School: lectures on interstitial lung disease
Priv.-Doz. Dr. Susanne Rittinghausen
University of Veterinary Medicine Hannover, Foundation: courses in toxicological pathology
Dr. Anton Roß
Hamburg University of Applied Sciences: lectures in Good Manufacturing Practice (GMP)
Dirk Schaudien Ph.D.
University of Veterinary Medicine Hannover, Foundation: lectures and courses in special and toxicological pathology
Dr. Sven Schuchardt
Kiel University: lectures on selected topics in toxicology and environmental medicine (as part of a lecture series)
Dr. Katherina Sewald
Hannover Medical School: lectures on allergy and asthma and on analgesics in the degree course “Biomedicine”; laboratory course in biomedicine; laboratory course in biochemistry: immunology
RWTH Aachen: lectures on immunotoxicology in the vocational degree course Laboratory Animal Science M. Sc.”
TRAIN Academy: lectures on immunotoxicology
Dr. Nataşa Stojanovic
University of Regensburg: course in pathology in the degree course “Molecular Medicine”
Dr. Henning Weigt
TRAIN Academy: lectures on “Preclinical development, phases, costs, and quality assurance”
Dr. Christian Werno
University of Regensburg: lectures on pathology and molecular oncology in the degree course “Molecular Medicine”; hands-on training in molecular oncology
Ostbayerische Technische Hochschule Regensburg: seminar "How does metastatic dissemination take place?" in the degree course “Medical Information Technology”
Prof. Dr. Holger Ziehr
RWTH Aachen: lectures on “Regulatory Affairs”
Technische Universität Braunschweig: lectures on applied and technical biochemistry
Fraunhofer Institute for Toxicology and Experimental Medicine